Macquarie Group’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,770
Closed -$60K 2566
2022
Q2
$60K Hold
5,770
﹤0.01% 2006
2022
Q1
$51 Hold
5,770
﹤0.01% 2136
2021
Q4
$40K Hold
5,770
﹤0.01% 2232
2021
Q3
$72K Buy
5,770
+4,393
+319% +$63.3K ﹤0.01% 2094
2021
Q2
$25K Hold
1,377
﹤0.01% 2322
2021
Q1
$29K Sell
1,377
-422
-23% -$8.89K ﹤0.01% 2199
2020
Q4
$32K Hold
1,799
﹤0.01% 2138
2020
Q3
$20K Hold
1,799
﹤0.01% 2169
2020
Q2
$25K Buy
+1,799
New +$24.8K ﹤0.01% 2126
2017
Q2
Sell
-18,415
Closed -$712K 1562
2017
Q1
$712K Sell
18,415
-572
-3% -$24K ﹤0.01% 1255
2016
Q4
$722K Buy
18,987
+3,263
+21% +$155K ﹤0.01% 1244
2016
Q3
$851K Sell
15,724
-24,916
-61% -$1.27M ﹤0.01% 1192
2016
Q2
$1.49M Buy
+40,640
New +$1.44M ﹤0.01% 1204

Other funds holding RDUS

Macquarie Group's RDUS Position: Q3 2022 in Review

Macquarie Group sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 5,770 shares — an estimated $60K sold.

Macquarie Group first reported a position in RDUS in Q2 2016 and held it in 13 quarters. The position peaked at $1.49M in Q2 2016. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

  • Macquarie Group reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 5,770 Radius Health, Inc. shares in Q3 2022, an estimated $60K.
  • Macquarie Group first reported a position in Radius Health, Inc. in Q2 2016 and held it in 13 quarters.
  • Macquarie Group's Radius Health, Inc. position peaked at $1.49M in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.